监管机构之间的协作现实世界证据:教训和观点
Andrew E Beck1, Melissa Kampman1, Cindy Huynh1
1Health Canada, Health Products and Food Branch, Marketed Health Products Directorate, Ottawa, Ontario, Canada.
Clinical pharmacology and therapeutics
|October 22, 2024
概括
国际药品监管机构联盟 (ICMRA) 工作组加强了针对COVID-19真实世界证据 (RWE) 和观察性研究的全球合作. 学到的经验教训将改善未来的公共卫生应急研究准备和响应.
科学领域:
- 监管科学 监管科学
- 公共卫生 公共卫生
- 制药政策 制药政策
背景情况:
- 国际药品监管机构联盟 (ICMRA) 联合了38个全球监管机构.
- 随着COVID-19的爆发,人们需要在现实世界的证据 (RWE) 和观察性研究方面进行国际合作.
- 利用现有的网络和基础设施来应对与流行病相关的研究挑战.
研究的目的:
- 评估ICMRA COVID-19现实世界证据 (RWE) 和观察研究工作组的有效性.
- 识别疫情期间从3年的合作研究中吸取的经验教训.
- 制定建议,以加强未来的公共卫生紧急情况的准备和应对.
主要方法:
- 专注于ICMRA COVID-19 RWE和观察研究工作组的活动.
- 进行了会员调查,以收集见解和经验.
- 分析了合作成果,包括研究和政策声明.
主要成果:
- 该工作组对RWE和疫苗安全性进行了有影响力的研究和声明.
- 主要课程强调了全球合作,快速决策治理和网络利用的重要性.
- 制定了建议,以加强国际研究合作和准备.
结论:
- 有效的沟通,协作研究和利用基础设施对于工作组的成功至关重要.
- 工作组的经验为未来的RWE战略实体提供了基础.
- 这些发现有助于改善全球公共卫生应急响应机制.
相关概念视频
Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
Drug Control Governance: Regulatory Bodies and Their Impact
144
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
144
Pharmacovigilance
778
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
778
Clinical Trials
6.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.6K
Clinical Trials: Overview
2.8K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.8K
Issues And Trends In Healthcare Delivery System
5.6K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.6K


